| dc.contributor.author | Tas, Faruk | |
| dc.contributor.author | Erturk, Kayhan | |
| dc.date.accessioned | 2021-12-10T13:09:08Z | |
| dc.date.available | 2021-12-10T13:09:08Z | |
| dc.identifier.citation | Tas F., Erturk K., "Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.", Japanese journal of clinical oncology, cilt.51, ss.873-878, 2021 | |
| dc.identifier.issn | 0368-2811 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_f1fc6c8b-92df-4b18-b407-b5b87aabf42e | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/175523 | |
| dc.identifier.uri | https://doi.org/10.1093/jjco/hyab031 | |
| dc.description.abstract | Background: Stage III melanoma is a heterogenous disease, and the number of tumor-involved lymph nodes is the most significantly unfavorable prognostic indicator for relapse and outcome. The aim of this study is to investigate the possible effects of the various clinicopathological factors on the course of node-positive stage III disease. | |
| dc.language.iso | eng | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Klinik Tıp | |
| dc.title | Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number. | |
| dc.type | Makale | |
| dc.relation.journal | Japanese journal of clinical oncology | |
| dc.contributor.department | İstanbul Üniversitesi , Onkoloji Enstitüsü , Klinik Onkoloji Ana Bilim Dalı | |
| dc.identifier.volume | 51 | |
| dc.identifier.startpage | 873 | |
| dc.identifier.endpage | 878 | |
| dc.contributor.firstauthorID | 2536758 | |
